First patient dosed with CUE-102 for recurrent glioblastoma multiforme (rGBM) at Dana-Farber Cancer Institute (DFCI) BOSTON, ...

The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...

Enzalutamide and other ARPIs are key in treating metastatic prostate cancer by blocking androgen receptors, improving patient ...

"If this receptor is impaired by genetic changes, mice show signs of loss of bone density at an early age—similar to osteoporosis in humans. Using the substance AP503, which was only recently ...

In a discovery that could guide the development of next-generation antidepressants and antipsychotic medications, researchers ...

In a discovery that could guide the development of next-generation antidepressants and antipsychotic medications, researchers ...

Dr. Jacob A. Sands shares how antibody-drug conjugates, such as Datroway, work to selectively target and destroy tumor cells ...

Researchers found a new adverse outcome pathway (AOP) for locomotor impairment initiated by TDCPP binding to integrin αvβ3 ...

This scientific review examines the potential of targeting the thyroid receptor β (TRβ) for developing new drugs to treat androgenetic alopecia, with the authors discussing various mechanisms by ...